OCUP - Ocuphire Pharma GAAP EPS of -$0.22 beats by $0.08 November, 04 2022 04:40 PM Ocuphire Pharma Inc Com Ocuphire Pharma press release ( NASDAQ: OCUP ): Q3 GAAP EPS of -$0.22 beats by $0.08 . As of September 30, 2022, Ocuphire had cash and cash equivalents of approximately $13.9M. For further details see: Ocuphire Pharma GAAP EPS of -$0.22 beats by $0.08